欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xanthomonas oryzae pv. oryzae 30S ribosomal protein S12 (rpsL) CSB-YP452783XBC
CSB-EP452783XBC
CSB-BP452783XBC
CSB-MP452783XBC
CSB-EP452783XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae 50S ribosomal protein L22 (rplV) CSB-YP452784XBC
CSB-EP452784XBC
CSB-BP452784XBC
CSB-MP452784XBC
CSB-EP452784XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae 50S ribosomal protein L18 (rplR) CSB-YP452785XBC
CSB-EP452785XBC
CSB-BP452785XBC
CSB-MP452785XBC
CSB-EP452785XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Chaperone protein DnaK (dnaK), partial CSB-YP452786XBC
CSB-EP452786XBC
CSB-BP452786XBC
CSB-MP452786XBC
CSB-EP452786XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP452787XBC
CSB-EP452787XBC
CSB-BP452787XBC
CSB-MP452787XBC
CSB-EP452787XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae 50S ribosomal protein L17 (rplQ) CSB-YP452788XBC
CSB-EP452788XBC
CSB-BP452788XBC
CSB-MP452788XBC
CSB-EP452788XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Methionine--tRNA ligase (metG), partial CSB-YP452789XBC
CSB-EP452789XBC
CSB-BP452789XBC
CSB-MP452789XBC
CSB-EP452789XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae 8-amino-7-oxononanoate synthase (bioF) CSB-YP452790XBC
CSB-EP452790XBC
CSB-BP452790XBC
CSB-MP452790XBC
CSB-EP452790XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Putative regulator of ribonuclease activity (PXO_04832) CSB-YP452791XBC
CSB-EP452791XBC
CSB-BP452791XBC
CSB-MP452791XBC
CSB-EP452791XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Coenzyme PQQ synthesis protein E (pqqE) CSB-YP452792XBC
CSB-EP452792XBC
CSB-BP452792XBC
CSB-MP452792XBC
CSB-EP452792XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP452793XBC
CSB-EP452793XBC
CSB-BP452793XBC
CSB-MP452793XBC
CSB-EP452793XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae 50S ribosomal protein L33 (rpmG) CSB-YP452794XBC
CSB-EP452794XBC
CSB-BP452794XBC
CSB-MP452794XBC
CSB-EP452794XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP452795XBC
CSB-EP452795XBC
CSB-BP452795XBC
CSB-MP452795XBC
CSB-EP452795XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae L-lactate dehydrogenase [cytochrome] (lldD) CSB-YP452796XBC
CSB-EP452796XBC
CSB-BP452796XBC
CSB-MP452796XBC
CSB-EP452796XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP452797XBC
CSB-EP452797XBC
CSB-BP452797XBC
CSB-MP452797XBC
CSB-EP452797XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae NADH-quinone oxidoreductase subunit D (nuoD) CSB-YP452798XBC
CSB-EP452798XBC
CSB-BP452798XBC
CSB-MP452798XBC
CSB-EP452798XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP452799XBC
CSB-EP452799XBC
CSB-BP452799XBC
CSB-MP452799XBC
CSB-EP452799XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas oryzae pv. oryzae Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP452800XBC
CSB-EP452800XBC
CSB-BP452800XBC
CSB-MP452800XBC
CSB-EP452800XBC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia phytofirmans UPF0250 protein Bphyt_0500 (Bphyt_0500) CSB-YP452801BXU
CSB-EP452801BXU
CSB-BP452801BXU
CSB-MP452801BXU
CSB-EP452801BXU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia phytofirmans NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP452802BXU
CSB-EP452802BXU
CSB-BP452802BXU
CSB-MP452802BXU
CSB-EP452802BXU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×